Literature DB >> 18030198

Assessment of global left and right ventricular function using dual-source computed tomography (DSCT) in comparison to MRI: an experimental study in a porcine model.

Philipp Bruners1, Andreas H Mahnken, Christian Knackstedt, Nadja Luhmann, Elmar Spüntrup, Marco Das, Christian Hohl, Joachim E Wildberger, Thomas Schmitz-Rode, Rolf W Günther, Georg Mühlenbruch.   

Abstract

OBJECTIVE: We sought to evaluate the ability of retrospectively ECG-gated dual-source computed tomography (DSCT) to assess left (LV) and right ventricular (RV) functional parameters in comparison to 1.5 T magnetic resonance imaging (MRI).
MATERIALS AND METHODS: Ten domestic pigs (60 kg) underwent both contrast-enhanced cardiac DSCT and cardiac MRI using standardized examination protocols under general anesthesia. From manually drawn endocardial and epicardial contours, LV and RV end-systolic (ESV) and end-diastolic volume (EDV), stroke volume (SV), ejection fraction (EF), myocardial mass (MM), peak filling rate (PFR), peak ejection rate (PER), time to peak ejection (TPE), and time to peak filling (TPF) were calculated by means of dedicated analysis software. LV and RV functional parameters were analyzed using Bland-Altman plots, Student t test, and Pearson's correlation coefficient.
RESULTS: Both left and right ESV and EDV, SV and EF determined with DSCT correlated well with MR imaging results (left, r = 0.98/0.92/0.82/0.98; right, r = 0.90/0.94/0.96/0.94). PER, PFR, TPE, TPF, and MM showed only a moderate to low correlation (left, r = 0.67/0.37/0.23/0.35/0.57; right, r = 0.78/0.69/0.12/0.11/0.44). PER and PFR were significantly underestimated by DSCT when compared with MRI.
CONCLUSIONS: Retrospectively ECG-gated DSCT correctly depicts end-systole and can accurately determine LV and RV volumes, SV, and EF in comparison to MRI. DSCT showed a significant underestimation of PER and PFR in comparison to MRI.

Entities:  

Mesh:

Year:  2007        PMID: 18030198     DOI: 10.1097/RLI.0b013e3180cc206f

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  6 in total

Review 1.  Assessment of coronary heart disease by CT angiography: current and evolving applications.

Authors:  Abhishek Sharma; Armin Arbab-Zadeh
Journal:  J Nucl Cardiol       Date:  2012-08       Impact factor: 5.952

2.  Accuracy and variability of right ventricular volumes and mass assessed by dual-source computed tomography: influence of slice orientation in comparison to magnetic resonance imaging.

Authors:  Christoph J Jensen; Alexander Wolf; Holger C Eberle; Michael Forsting; Kai Nassenstein; Thomas C Lauenstein; Georg V Sabin; Oliver Bruder; Thomas Schlosser
Journal:  Eur Radiol       Date:  2011-07-27       Impact factor: 5.315

3.  Performance of Automated Software in the Assessment of Segmental Left Ventricular Function in Cardiac CT: Comparison with Cardiac Magnetic Resonance.

Authors:  Rui Wang; Felix G Meinel; U Joseph Schoepf; Christian Canstein; James V Spearman; Carlo N De Cecco
Journal:  Eur Radiol       Date:  2015-04-30       Impact factor: 5.315

4.  Feasibility of a radiation dose conserving CT protocol for myocardial function assessment.

Authors:  A Pursnani; A Lee; T Mayrhofer; M Panagia; U Sharma; S Abbara; U Hoffmann; B B Ghoshhajra
Journal:  Br J Radiol       Date:  2014-06-02       Impact factor: 3.039

5.  CT for evaluation of myocardial cell therapy in heart failure: a comparison with CMR imaging.

Authors:  Karl H Schuleri; Marco Centola; Seong Hoon Choi; Kristine S Evers; Fady Dawoud; Richard T George; João A C Lima; Albert C Lardo
Journal:  JACC Cardiovasc Imaging       Date:  2011-12

6.  Automatic detection of left and right ventricles from CTA enables efficient alignment of anatomy with myocardial perfusion data.

Authors:  Marina Piccinelli; Tracy L Faber; Chesnal D Arepalli; Vikram Appia; Jakob Vinten-Johansen; Susan L Schmarkey; Russell D Folks; Ernest V Garcia; Anthony Yezzi
Journal:  J Nucl Cardiol       Date:  2013-11-02       Impact factor: 5.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.